Prognostic value of simultaneous [ <sup>18</sup> F]FDG‐PET/MRI in refractory multiple myeloma treated with anti‐BCMA CAR T

Bastien Jamet, Huajun Sun, Chloé François, Hatem Necib, Aurélien Monnet, Éric Frampas, Nicolas Blin, Nicoletta Libera Lilli, Caroline Bodet‐Milin, Philippe Moreau, Françoise Kraeber‐Bodere, Cyrille Touzeau

Open source

DOI
10.1002/hem3.70515
Published
2026-10
Container
HemaSphere
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70515,
  title = {Prognostic value of simultaneous [
                    <sup>18</sup>
                    F]FDG‐PET/MRI in refractory multiple myeloma treated with anti‐BCMA CAR T},
  author = {Bastien Jamet and Huajun Sun and Chloé François and Hatem Necib and Aurélien Monnet and Éric Frampas and Nicolas Blin and Nicoletta Libera Lilli and Caroline Bodet‐Milin and Philippe Moreau and Françoise Kraeber‐Bodere and Cyrille Touzeau},
  year = {2026},
  journal = {HemaSphere},
  doi = {10.1002/hem3.70515},
  url = {https://doi.org/10.1002/hem3.70515}
}

RIS

TY  - JOUR
TI  - Prognostic value of simultaneous [
                    <sup>18</sup>
                    F]FDG‐PET/MRI in refractory multiple myeloma treated with anti‐BCMA CAR T
AU  - Bastien Jamet
AU  - Huajun Sun
AU  - Chloé François
AU  - Hatem Necib
AU  - Aurélien Monnet
AU  - Éric Frampas
AU  - Nicolas Blin
AU  - Nicoletta Libera Lilli
AU  - Caroline Bodet‐Milin
AU  - Philippe Moreau
AU  - Françoise Kraeber‐Bodere
AU  - Cyrille Touzeau
PY  - 2026
JO  - HemaSphere
DO  - 10.1002/hem3.70515
UR  - https://doi.org/10.1002/hem3.70515
ER  - 

APA

Jamet, B., Sun, H., François, C., Necib, H., Monnet, A., Frampas, É., Blin, N., Lilli, N. L., Bodet‐Milin, C., Moreau, P., Kraeber‐Bodere, F., & Touzeau, C. (2026). Prognostic value of simultaneous [ <sup>18</sup> F]FDG‐PET/MRI in refractory multiple myeloma treated with anti‐BCMA CAR T. HemaSphere. https://doi.org/10.1002/hem3.70515

Source records